Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Galectin 3"" wg kryterium: Temat


Tytuł:
Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S···O binding interaction for drug design.
Autorzy:
Liu C; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States. Electronic address: .
Wang W; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Feng J; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Beno B; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Raja T; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Swidorski J; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Manepalli RKVLP; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Vetrichelvan M; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Rao Jalagam P; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Nair SK; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Gupta A; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Panda M; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Ghosh K; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Kaushikkumar Shukla J; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Sale H; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Shah D; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Singh Gautam S; Biocon-Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
Patel D; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Mathur A; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Ellsworth BA; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Cheng D; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Regueiro-Ren A; Research & Early Development, Bristol Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543, United States.
Pokaż więcej
Źródło:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Mar 01; Vol. 101, pp. 117638. Date of Electronic Publication: 2024 Feb 11.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/chemistry
Galectin 3*/metabolism
Monosaccharides*
Humans ; Animals ; Mice ; Galectins/chemistry ; Benzothiazoles/pharmacology ; Drug Design ; Oxygen ; Sulfur
Czasopismo naukowe
Tytuł:
Galectin-3 aggravates microglial activation and tau transmission in tauopathy.
Autorzy:
Siew JJ; Institute of Biomedical Sciences.
Chen HM; Institute of Biomedical Sciences.
Chiu FL; Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
Lee CW; Institute of Biomedical Sciences.
Chang YM; Institute of Biomedical Sciences.
Chen HL; Institute of Biomedical Sciences.
Nguyen TNA; Institute of Biomedical Sciences.
Liao HT; Institute of Biomedical Sciences.
Liu M; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA.
Hagar HT; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA.
Sun YC; Institute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Lai HL; Institute of Biomedical Sciences.
Kuo MH; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA.
Blum D; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.; Alzheimer & Tauopathies, LabEx DISTALZ, LiCEND, Lille, France.
Buée L; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.; Alzheimer & Tauopathies, LabEx DISTALZ, LiCEND, Lille, France.
Jin LW; Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, California, USA.
Chen SY; Institute of Biomedical Sciences.
Ko TM; Institute of Biomedical Sciences.; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Huang JR; Institute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Kuo HC; Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
Liu FT; Institute of Biomedical Sciences.
Chern Y; Institute of Biomedical Sciences.
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2024 Jan 16; Vol. 134 (2). Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/genetics
Galectin 3*/metabolism
tau Proteins*/genetics
tau Proteins*/metabolism
Tauopathies*/genetics
Tauopathies*/metabolism
Animals ; Humans ; Mice ; Alzheimer Disease/pathology ; Disease Models, Animal ; Induced Pluripotent Stem Cells/metabolism ; Mice, Transgenic ; Microglia/pathology
Czasopismo naukowe
Tytuł:
Biophysical and Structural Characterization of the Interaction between Human Galectin-3 and the Lipopolysaccharide from Pseudomonas aeruginosa .
Autorzy:
Pirone L; Institute of Biostructures and Bioimaging, National Research Council (CNR), Via P. Castellino 111, 80131 Naples, Italy.
Lenza MP; Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Di Gaetano S; Institute of Biostructures and Bioimaging, National Research Council (CNR), Via P. Castellino 111, 80131 Naples, Italy.; Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Capasso D; Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.; Department of Physics 'Ettore Pancini', University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Filocaso M; Institute of Biostructures and Bioimaging, National Research Council (CNR), Via P. Castellino 111, 80131 Naples, Italy.; Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.; Institute of Crystallography, National Research Council (CNR), 81100 Caserta, Italy.
Russo R; Institute of Biostructures and Bioimaging, National Research Council (CNR), Via P. Castellino 111, 80131 Naples, Italy.; Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.
Di Carluccio C; Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Saviano M; Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.; Institute of Crystallography, National Research Council (CNR), 81100 Caserta, Italy.
Silipo A; Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Pedone E; Institute of Biostructures and Bioimaging, National Research Council (CNR), Via P. Castellino 111, 80131 Naples, Italy.; Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 01; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*
Lipopolysaccharides*
Humans ; Pseudomonas aeruginosa ; Galectins
Czasopismo naukowe
Tytuł:
Injured sensory neurons-derived galectin-3 contributes to neuropathic pain via programming microglia in the spinal dorsal horn.
Autorzy:
Shan L; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Xu K; Department of Anesthesiology, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Ji L; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Zeng Q; Department of Anesthesiology, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, The 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China.
Liu Y; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Wu Y; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Chen Y; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Li Y; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Hu Q; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Wu J; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Xu Y; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Luo Y; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, The 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China.
Li C; Guangdong Institute of Intelligence Science and Technology, Hengqin, Zhuhai, Guangdong, China.
Wu C; Department of Anesthesiology, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
Jiang C; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, The 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China. Electronic address: .
Wang Z; Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China; Key University Laboratory of Metabolism and Health of Guangdong School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China; SUSTech Center for Pain Medicine, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. Electronic address: .
Pokaż więcej
Źródło:
Brain, behavior, and immunity [Brain Behav Immun] 2024 Mar; Vol. 117, pp. 80-99. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Galectin 3*/genetics
Neuralgia*
Animals ; Mice ; Hyperalgesia ; Microglia ; Sensory Receptor Cells
Czasopismo naukowe
Tytuł:
PRKAA2, MTOR, and TFEB in the regulation of lysosomal damage response and autophagy.
Autorzy:
Shariq M; Quantlase Imaging Laboratory, Quantlase Lab LLC, Unit 1-8, Masdar City, Abu Dhabi, UAE. .
Khan MF; Quantlase Imaging Laboratory, Quantlase Lab LLC, Unit 1-8, Masdar City, Abu Dhabi, UAE. .
Raj R; Quantlase Imaging Laboratory, Quantlase Lab LLC, Unit 1-8, Masdar City, Abu Dhabi, UAE.
Ahsan N; Quantlase Imaging Laboratory, Quantlase Lab LLC, Unit 1-8, Masdar City, Abu Dhabi, UAE.
Kumar P; Quantlase Imaging Laboratory, Quantlase Lab LLC, Unit 1-8, Masdar City, Abu Dhabi, UAE.
Pokaż więcej
Źródło:
Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2024 Mar; Vol. 102 (3), pp. 287-311. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Galectin 3*/metabolism
DNA Helicases*
Poly-ADP-Ribose Binding Proteins/metabolism ; RNA Helicases/metabolism ; RNA Recognition Motif Proteins/metabolism ; Autophagy/genetics ; TOR Serine-Threonine Kinases/metabolism ; Lysosomes/metabolism ; GTP Phosphohydrolases/metabolism ; Endosomal Sorting Complexes Required for Transport/metabolism ; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Time-course analysis of liver and serum galectin-3 in acute liver injury after alpha-galactosylceramide injection.
Autorzy:
Matsuo M; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kanbe A; Division of Clinical Laboratory, Gifu University Hospital, Gifu, Japan.
Noguchi K; Department of Pathology, Gifu Prefectural General Medical Center, Gifu, Japan.
Niwa A; Department of Diagnostic Pathology, Gifu University Hospital, Gifu Japan.
Imaizumi Y; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kuroda T; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Ichihashi K; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Okubo T; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Mori K; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kanayama T; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Tomita H; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.; Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan.
Hara A; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 08; Vol. 19 (2), pp. e0298284. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/metabolism
Liver Diseases*/pathology
Galactosylceramides*
Animals ; Calcium ; Liver/metabolism ; Biomarkers
Czasopismo naukowe
Tytuł:
Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape.
Autorzy:
Scafetta G; Pathology Research Laboratory St, Andrea University Hospital, Via Di Grottarossa 1035, 00189, Rome, Italy.
D'Alessandria C; Klinikum Rechts Der Isar, Nuclear Medicine Department, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.
Bartolazzi A; Pathology Research Laboratory St, Andrea University Hospital, Via Di Grottarossa 1035, 00189, Rome, Italy. .; Pathology Research Laboratory Cancer Center Karolinska, Karolinska Hospital, S-17176, Stockholm, Sweden. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 06; Vol. 43 (1), pp. 41. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Letter
MeSH Terms:
Galectin 3*/genetics
Immunotherapy*
Neoplasms*/immunology
Neoplasms*/pathology
Humans ; Tumor Escape ; Tumor Microenvironment
Opinia redakcyjna
Tytuł:
Saturation Transfer Difference NMR and Molecular Docking Interaction Study of Aralkyl-Thiodigalactosides as Potential Inhibitors of the Human-Galectin-3 Protein.
Autorzy:
Hőgye F; Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Farkas LB; Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.; HUN-REN-UD Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Balogh ÁK; HUN-REN-UD Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Szilágyi L; Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Alnukari S; HUN-REN-UD Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Bajza I; GlycOptim Kft., Egyetem tér 1, H-4032 Debrecen, Hungary.
Borbás A; HUN-REN-UD Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.; Department of Pharmaceutical Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Fehér K; HUN-REN-UD Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Illyés TZ; Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Timári I; Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.; HUN-REN-UD Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/antagonists & inhibitors
Thiogalactosides*/chemistry
Thiogalactosides*/pharmacology
Humans ; Magnetic Resonance Spectroscopy ; Models, Molecular ; Molecular Docking Simulation ; Protein Binding
Czasopismo naukowe
Tytuł:
Association between galectin-3 and the prognosis of patients with stroke: A meta-analysis of observational studies.
Autorzy:
Zhang X; Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Yang L; The First People's Hospital of Xiaoshan District, China.
Zhang J; Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Huang P; Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Jin Z; Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Liu Y; Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Zeng D; Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: .
Pokaż więcej
Źródło:
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2024 Feb; Vol. 34 (2), pp. 270-280. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Galectin 3*
Stroke*/diagnosis
Stroke*/therapy
Humans ; Databases, Factual ; Prognosis ; Survivors
Czasopismo naukowe
Tytuł:
Enzymatically-derived oligo-carrageenans interact with α-Gal antibodies and Galectin-3.
Autorzy:
Sokolova E; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France.
Jouanneau D; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France.
Chevenier A; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France.
Jam M; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France.
Desban N; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France.
Colas P; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France.
Ficko-Blean E; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France. Electronic address: .
Michel G; Sorbonne Université, CNRS, Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), 29680 Roscoff, Bretagne, France. Electronic address: .
Pokaż więcej
Źródło:
Carbohydrate polymers [Carbohydr Polym] 2024 Jan 15; Vol. 324, pp. 121563. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/metabolism
Galactose*
Humans ; Carrageenan/chemistry ; Galectins ; Oligosaccharides/chemistry ; Antibodies
Czasopismo naukowe
Tytuł:
Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients.
Autorzy:
Kim JH; Department of Internal Medicine and Kidney Research Institute, Hallym University Sacred Heart Hospital, Pyungan-dong, Dongan-gu, Anyang, 431-070, Korea.
Noh HM; Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
Song HJ; Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
Lee S; Department of Statistics and Institute of Statistics, Hallym University, Chuncheon, Korea.
Kim SG; Department of Internal Medicine and Kidney Research Institute, Hallym University Sacred Heart Hospital, Pyungan-dong, Dongan-gu, Anyang, 431-070, Korea.
Kim JK; Department of Internal Medicine and Kidney Research Institute, Hallym University Sacred Heart Hospital, Pyungan-dong, Dongan-gu, Anyang, 431-070, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 10; Vol. 14 (1), pp. 939. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*
Vascular Calcification*
Humans ; Galectins ; Heart Disease Risk Factors ; Renal Dialysis/adverse effects
Czasopismo naukowe
Tytuł:
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.
Autorzy:
Schadeck J; Institute of Immunology, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Oberg HH; Institute of Immunology, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Peipp M; Divison of Antibody-Based Immunotherapy, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Hedemann N; Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany.
Schamel WW; Signalling Research Centre Biological Signalling Studies (BIOSS) and Centre of Integrative Biological Signalling Studies (CIBSS), Faculty of Biology, University of Freiburg, Freiburg, Germany.; Centre for Chronic Immunodeficiency (CCI), Medical Centre Freiburg, and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bauerschlag D; Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany.
Wesch D; Institute of Immunology, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 08; Vol. 14, pp. 1286097. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/genetics
Ovarian Neoplasms*/therapy
Female ; Humans ; Carcinoma, Ovarian Epithelial ; Cell Proliferation ; Coculture Techniques ; Immunosuppressive Agents
Czasopismo naukowe
Tytuł:
Intermittent Fasting Reduces Neuroinflammation and Cognitive Impairment in High-Fat Diet-Fed Mice by Downregulating Lipocalin-2 and Galectin-3.
Autorzy:
Lee J; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
An HS; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
Shin HJ; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
Jang HM; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
Im CO; Department of Medicine, College of Medicine, Gyeongsang National University, Jinju 52727, Republic of Korea.
Jeong Y; Department of Medicine, College of Medicine, Gyeongsang National University, Jinju 52727, Republic of Korea.
Eum K; Department of Medicine, College of Medicine, Gyeongsang National University, Jinju 52727, Republic of Korea.
Yoon S; Department of Medicine, College of Medicine, Gyeongsang National University, Jinju 52727, Republic of Korea.
Lee SJ; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
Jeong EA; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
Kim KE; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
Roh GS; Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
Pokaż więcej
Źródło:
Nutrients [Nutrients] 2024 Jan 03; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*
Cognitive Dysfunction*/etiology
Cognitive Dysfunction*/prevention & control
Animals ; Mice ; Neuroinflammatory Diseases ; Diet, High-Fat/adverse effects ; Lipocalin-2 ; Intermittent Fasting
Czasopismo naukowe
Tytuł:
Dynein functions in galectin-3 mediated processes of clathrin-independent endocytosis.
Autorzy:
Mayya C; Biological Engineering, Indian Institute of Technology Gandhinagar, Gandhinagar 382 355, India.
Naveena AH
Sinha P
Bhatia D
Pokaż więcej
Źródło:
Journal of biosciences [J Biosci] 2024; Vol. 49.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/genetics
Endocytosis*/genetics
Biological Transport ; Clathrin ; Dyneins
Czasopismo naukowe
Tytuł:
Isomerization of proline-46 in the N-terminal tail of galectin-3 enhances T cell apoptosis via the ROS-ERK pathway.
Autorzy:
Zhao Z; Engineering Research Center of Glycoconjugates, Ministry of Education, Jilin Province Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, China.
Wang M; Engineering Research Center of Glycoconjugates, Ministry of Education, Jilin Province Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, China.
Miller MC; Department of Biochemistry, Molecular Biology & Biophysics, 6-155 Jackson Hall, University of Minnesota, Minneapolis, MN 55455, USA.
He Z; Engineering Research Center of Glycoconjugates, Ministry of Education, Jilin Province Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, China.
Xu X; Engineering Research Center of Glycoconjugates, Ministry of Education, Jilin Province Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, China.
Zhou Y; Engineering Research Center of Glycoconjugates, Ministry of Education, Jilin Province Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, China.
Mayo KH; Department of Biochemistry, Molecular Biology & Biophysics, 6-155 Jackson Hall, University of Minnesota, Minneapolis, MN 55455, USA.
Tai G; Engineering Research Center of Glycoconjugates, Ministry of Education, Jilin Province Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun 130024, China. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2024 Jan; Vol. 256 (Pt 1), pp. 128304. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/metabolism
MAP Kinase Signaling System*
Reactive Oxygen Species/metabolism ; Isomerism ; Proline/chemistry ; Galectins/metabolism ; Carbohydrates/chemistry ; Apoptosis ; T-Lymphocytes/metabolism
Czasopismo naukowe
Tytuł:
Prognostic utility of serum NT-proBNP (fragments 1-76aa and 13-71aa) and galectin-3 in predicting death and re-hospitalisation due to cardiovascular events in patients with heart failure.
Autorzy:
Zhang X; Saliva and Liquid Biopsy Translational Laboratory, Griffith Institute for Drug Discovery, Griffith University, 46, Don Young Rd, Nathan, QLD, 4111, Australia.; Menzies Health Institute Queensland (MHIQ), Griffith University, Gold Coast, QLD, Australia.
Wan Y; Saliva and Liquid Biopsy Translational Laboratory, The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
Karunathilaka N; Saliva and Liquid Biopsy Translational Laboratory, Griffith Institute for Drug Discovery, Griffith University, 46, Don Young Rd, Nathan, QLD, 4111, Australia.; Menzies Health Institute Queensland (MHIQ), Griffith University, Gold Coast, QLD, Australia.
Chan W; The Prince Charles Hospital, Brisbane, QLD, Australia.; School of Medicine, University of Queensland, Brisbane, Australia.
Kostner K; Department of Cardiology, Mater Adult Hospital, Brisbane, QLD, Australia.
Hartel G; Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Coats AJS; Faculty of Medicine, Monash University, Melbourne, VIC, Australia.; University of Warwick, Coventry, UK.; Monash University, Clayton, Australia.
Atherton JJ; Cardiology Department, Faculty of Medicine, Royal Brisbane and Women's Hospital and University of Queensland, Brisbane, QLD, Australia.
Punyadeera C; Saliva and Liquid Biopsy Translational Laboratory, Griffith Institute for Drug Discovery, Griffith University, 46, Don Young Rd, Nathan, QLD, 4111, Australia. .; Saliva and Liquid Biopsy Translational Laboratory, The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia. .; Translational Research Institute, Woolloongabba, Australia. .; Menzies Health Institute Queensland (MHIQ), Griffith University, Gold Coast, QLD, Australia. .
Pokaż więcej
Źródło:
Heart and vessels [Heart Vessels] 2024 Jan; Vol. 39 (1), pp. 86-94. Date of Electronic Publication: 2023 Aug 03.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*
Heart Failure*
Humans ; Prognosis ; Natriuretic Peptide, Brain ; Peptide Fragments ; Biomarkers ; Hospitalization
Czasopismo naukowe
Tytuł:
Galectin-3 contributes to acute cardiac dysfunction and toxicity by increasing oxidative stress and fibrosis in doxorubicin-treated mice.
Autorzy:
Seropian IM; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina; Servicio de Hemodinamia y Cardiología Intervencionista, Hospital Italiano de Buenos Aires, Argentina.
Fontana Estevez FS; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina.
Villaverde A; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina.
Cacciagiú L; Hospital General de Agudos Teodoro Álvarez, Laboratorio Central, Sección Bioquímica, Argentina.
Bustos R; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina.
Touceda V; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina.
Penas F; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Selser C; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina.
Morales C; Universidad de Buenos Aires, Facultad de Medicina, Departamento de Patología, Buenos Aires, Argentina.
Miksztowicz V; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina.
González GE; Pontificia Universidad Católica Argentina, Facultad de Medicina, Instituto de Investigaciones Biomédicas UCA-CONICET, Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina. Electronic address: .
Pokaż więcej
Źródło:
International journal of cardiology [Int J Cardiol] 2023 Dec 15; Vol. 393, pp. 131386. Date of Electronic Publication: 2023 Sep 22.
Typ publikacji:
Journal Article
MeSH Terms:
Galectin 3*/genetics
Galectin 3*/metabolism
Cardiomyopathies*/metabolism
Humans ; Mice ; Male ; Animals ; Thiobarbituric Acid Reactive Substances/adverse effects ; Thiobarbituric Acid Reactive Substances/metabolism ; Doxorubicin/toxicity ; Oxidative Stress ; Myocytes, Cardiac/metabolism ; Mice, Knockout ; Cardiotoxicity/metabolism ; Fibrosis ; Inflammation/metabolism ; Apoptosis
Czasopismo naukowe
Tytuł:
Galectin-3 and suppression of tumorigenicity 2: Two emerging cardiac biomarkers that may be predictors of cardiac fibrosis development in sport.
Autorzy:
Goff CL; Clinical Chemistry Department, University Hospital of Liege, Liege, Belgium.
Pokaż więcej
Źródło:
Experimental physiology [Exp Physiol] 2023 Oct; Vol. 108 (10), pp. 1257-1258. Date of Electronic Publication: 2023 Aug 28.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Fibrosis*/genetics
Fibrosis*/pathology
Galectin 3*/analysis
Galectin 3*/genetics
Heart Diseases*/genetics
Heart Diseases*/metabolism
Heart Diseases*/pathology
Interleukin-1 Receptor-Like 1 Protein*/analysis
Interleukin-1 Receptor-Like 1 Protein*/genetics
Sports*
Humans ; Biomarkers/analysis
Czasopismo naukowe
Tytuł:
Discovery of Selective and Orally Available Galectin-1 Inhibitors.
Autorzy:
Zetterberg FR; Galecto Biotech AB, Sahlgrenska Science Park, Medicinaregatan 8 A, SE-413 46 Gothenburg, Sweden.
Diehl C; SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden.
Håkansson M; SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden.
Kahl-Knutson B; Department of Laboratory Medicine, Lund University, Box 124, SE-221 00, Lund, Sweden.
Leffler H; Department of Laboratory Medicine, Lund University, Box 124, SE-221 00, Lund, Sweden.
Nilsson UJ; Galecto Biotech AB, Sahlgrenska Science Park, Medicinaregatan 8 A, SE-413 46 Gothenburg, Sweden.; Department of Chemistry, Lund University, Box 124, SE-221 00 Lund, Sweden.
Peterson K; Galecto Biotech AB, Sahlgrenska Science Park, Medicinaregatan 8 A, SE-413 46 Gothenburg, Sweden.
Roper JA; Stevenage Bioscience Catalyst, Galecto Biotech ApS, Stevenage, Hertfordshire SG1 2FX U.K.
Slack RJ; Stevenage Bioscience Catalyst, Galecto Biotech ApS, Stevenage, Hertfordshire SG1 2FX U.K.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2023 Dec 28; Vol. 66 (24), pp. 16980-16990. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Galectin 1*/chemistry
Galectin 1*/metabolism
Galectin 3*/metabolism
Humans ; Animals ; Mice ; Binding Sites ; Carbohydrates/chemistry ; Jurkat Cells
Czasopismo naukowe
Tytuł:
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
Autorzy:
Woś J; Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Szymańska A; Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Lehman N; Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Chocholska S; Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-080 Lublin, Poland.
Zarobkiewicz M; Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Pożarowski P; Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Bojarska-Junak A; Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Dec 22; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Galectin 3*/genetics
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Humans ; B-Lymphocytes ; Biomarkers ; Proto-Oncogene Proteins c-bcl-2/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies